130 related articles for article (PubMed ID: 1423834)
1. Peroxisome proliferation and resistance to hydrogen peroxide in rat hepatocytes: is development of resistance an adaptation to cytotoxicity?
Garberg P; Stenius U; Nilsson K; Högberg J
Carcinogenesis; 1992 Oct; 13(10):1751-8. PubMed ID: 1423834
[TBL] [Abstract][Full Text] [Related]
2. Long-term effects of hypolipidemic peroxisome proliferator administration on hepatic hydrogen peroxide metabolism in rats.
Tamura H; Iida T; Watanabe T; Suga T
Carcinogenesis; 1990 Mar; 11(3):445-50. PubMed ID: 2311188
[TBL] [Abstract][Full Text] [Related]
3. Studies on Se incorporation in selenoproteins; effects of peroxisome proliferators and hydrogen peroxide generating system.
Garberg P; Högberg J
Chem Biol Interact; 1992 Feb; 81(3):291-306. PubMed ID: 1540996
[TBL] [Abstract][Full Text] [Related]
4. In vitro steady-state levels of hydrogen peroxide after exposure of male F344 rats and female B6C3F1 mice to hepatic peroxisome proliferators.
Tomaszewski KE; Agarwal DK; Melnick RL
Carcinogenesis; 1986 Nov; 7(11):1871-6. PubMed ID: 3769136
[TBL] [Abstract][Full Text] [Related]
5. Long-term effects of peroxisome proliferators on the balance between hydrogen peroxide-generating and scavenging capacities in the liver of Fischer-344 rats.
Tamura H; Iida T; Watanabe T; Suga T
Toxicology; 1990 Aug; 63(2):199-213. PubMed ID: 2399535
[TBL] [Abstract][Full Text] [Related]
6. gamma-Glutamyltranspeptidase-positive rat hepatocytes are protected from GSH depletion, oxidative stress and reversible alterations of collagen receptors.
Stenius U; Rubin K; Gullberg D; Högberg J
Carcinogenesis; 1990 Jan; 11(1):69-73. PubMed ID: 1967230
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the hepatic effects of nafenopin and WY-14,643 on peroxisome proliferation and cell replication in the rat and Syrian hamster.
Lake BG; Evans JG; Cunninghame ME; Price RJ
Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):241-7. PubMed ID: 8013414
[TBL] [Abstract][Full Text] [Related]
8. Nafenopin, a peroxisome proliferator, depletes hepatic vitamin E content and elevates plasma oxidised glutathione levels in rats.
Lake BG; Gray TJ; Körösi SA; Walters DG
Toxicol Lett; 1989 Feb; 45(2-3):221-9. PubMed ID: 2919403
[TBL] [Abstract][Full Text] [Related]
9. Induction of acyl-CoA oxidase and cytochrome P450IVA1 RNA in rat primary hepatocyte culture by peroxisome proliferators.
Bell DR; Elcombe CR
Biochem J; 1991 Nov; 280 ( Pt 1)(Pt 1):249-53. PubMed ID: 1720616
[TBL] [Abstract][Full Text] [Related]
10. Genetic differences in enzymes associated with peroxisome proliferation and hydrogen peroxide metabolism in inbred mouse strains.
Butler EG; England PJ; Williams GM
Carcinogenesis; 1988 Aug; 9(8):1459-63. PubMed ID: 3402042
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator nafenopin potentiated cytotoxicity and genotoxicity of cyclophosphamide in the liver and bone marrow cells.
Voskoboinik I; Drew R; Ahokas JT
Chem Biol Interact; 1997 Jul; 105(2):81-97. PubMed ID: 9251722
[TBL] [Abstract][Full Text] [Related]
12. Glutathione S-transferase isoenzyme patterns in different subtypes of enzyme-altered rat liver foci treated with the peroxisome proliferator nafenopin or with phenobarbital.
Grasl-Kraupp B; Waldhör T; Huber W; Schulte-Hermann R
Carcinogenesis; 1993 Nov; 14(11):2407-12. PubMed ID: 8242872
[TBL] [Abstract][Full Text] [Related]
13. The peroxisome proliferator class of non-genotoxic hepatocarcinogens synergize with epidermal growth factor to promote clonal expansion of initiated rat hepatocytes.
James NH; Roberts RA
Carcinogenesis; 1994 Dec; 15(12):2687-94. PubMed ID: 8001222
[TBL] [Abstract][Full Text] [Related]
14. Differential effect of peroxisome proliferators on rat glutathione S-transferase isoenzymes.
Voskoboinik I; Drew R; Ahokas JT
Toxicol Lett; 1996 Oct; 87(2-3):147-55. PubMed ID: 8914623
[TBL] [Abstract][Full Text] [Related]
15. Use of primary cultures of adult rat hepatocytes to investigate mechanisms of action of nafenopin, a hepatocarcinogenic peroxisome proliferator.
Bieri F; Bentley P; Waechter F; Stäubli W
Carcinogenesis; 1984 Aug; 5(8):1033-9. PubMed ID: 6146407
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferation and lipid peroxidation in rat liver.
Goel SK; Lalwani ND; Reddy JK
Cancer Res; 1986 Mar; 46(3):1324-30. PubMed ID: 3943099
[TBL] [Abstract][Full Text] [Related]
17. Role of fatty acyl coenzyme A oxidase in the efflux of oxidized glutathione from perfused livers of rats treated with the peroxisome proliferator nafenopin.
Conway JG; Neptun DA; Garvey LK; Popp JA
Cancer Res; 1987 Sep; 47(18):4795-800. PubMed ID: 3621175
[TBL] [Abstract][Full Text] [Related]
18. Role of hepatic non-parenchymal cells in the response of rat hepatocytes to the peroxisome proliferator nafenopin in vitro.
Hasmall SC; West DA; Olsen K; Roberts RA
Carcinogenesis; 2000 Dec; 21(12):2159-65. PubMed ID: 11133804
[TBL] [Abstract][Full Text] [Related]
19. An in vitro model of rodent nongenotoxic hepatocarcinogenesis.
James NH; Molloy CA; Soames AR; French NJ; Roberts RA
Exp Cell Res; 1992 Dec; 203(2):407-19. PubMed ID: 1281111
[TBL] [Abstract][Full Text] [Related]
20. Potent peroxisome proliferators inhibit beta-oxidation in the isolated perfused rat liver.
Bojes HK; Thurman RG
Toxicol Appl Pharmacol; 1996 Oct; 140(2):322-7. PubMed ID: 8887448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
